Joseph Keegan has been named president and CEO of ForteBio, effective Sept. 24. Keegan joins the firm from Molecular Devices, where he served as president and CEO until the firm was acquired earlier this year by MDS. Keegan replaces founding CEO Winnie Wan, who will continue to serve on ForteBio’s board of directors.
Affymetrix said this week that Kevin King has been promoted from president of the life sciences business and executive vice president to president of the company. King joined Affy in January from Thomson Healthcare, where he served as president and CEO. He is a former vice president and general manager of global clinical systems for GE Healthcare.
The Pittsburgh Life Sciences Greenhouse has elected several new members to its board of directors. Electees include Peter DeComo, chairman and CEO of Renal Solutions; John Kuzmishin, VP of strategic business initiatives at the University of Pittsburgh Medical Center; John Miclot, president and CEO of Respironics; and Elizabeth Woo, VP of biotechnology for Thermo Fisher Scientific.
Epitome Biosystems has named Edward Machuga VP of sales and marketing. Machuga previously served in sales and marketing roles at GE Healthcare, TekCel, Argonaut Technologies, Applied Biosystems, and Perseptive Biosystems.